Gastrointestinal stromal tumour: From the clinic to the molecules
Journal Title: Journal of Cancer Research & Therapy - Year 2014, Vol 2, Issue 3
Abstract
GastroIntestional stromal tumours (GISTs), the most frequent sarcoma in the gastro-intestinal (GI) tract, are highly resistant to conventional chemotherapy and radiotherapy. These tumours have activating mutations in two closely related genes, KIT (75-80%) or/and PDGFRA (5-10%). Targeting these mutated activated proteins with imatinib mesylate has proven efficient in the treatment of GISTs. The median survival after diagnosis of GIST increased from 1.5 to 4.8 years with imatinib treatment. However, resistance to imatinib eventually develops and new-targeted therapies are needed. This paper reviews the medical, clinical and pathological aspects of GISTs based on latest research in human cell lines and animal models.
Authors and Affiliations
Hapkova I, Bernex F, Barbara PDS, Vesely J
Keywords
Related Articles
- EP ID EP547367
- DOI 10.14312/2052-4994.2014-8
- Views 90
- Downloads 0
Therapy-related acute myeloid leukemia with chromosomal abnormalities involving t(9;22)(q34;q11) and t(3;21)(q26;q22) during chemotherapy for follicular lymphoma
This report describes a case of a patient who developed therapy-related acute myeloid leukemia five years after initiating chemotherapy for follicular lymphoma. The patient had been treated with multiple chemotherapeutic...
Malignant solitary fibrous tumor of the sacrum: A case report
The solitary fibrous tumor (SFT) is a rare ubiquitous mesenchymal neoplasm of fibroblastic type, which shows a prominent hemangiopericytoma-like branching vascular pattern. Approximately 40% of solitary fibrous tumors ar...
HTLV-1 can be involved in acceleration of different nonhematological cancers
In the past two decades it has been found that viral proteins might contribute to activation of numerous pathways involved in different types of cancer. Human T-lymphotropic virus 1 (HTLV-1), well known as a cause of T-c...
Clinical study of the treatment of multiple brain metastases from adenocarcinoma of the lung by simultaneous integrated boost intensity-modulated radiotherapy
Objective: To investigate the effects of simultaneous integrated boost intensity-modulated radiotherapy (SIB) and sequential boost conformal radiotherapy (CRT) in treatment of multiple brain metastases from lung adenocar...
Outcomes of social support programs in brain cancer survivors in an Australian community cohort: a prospective study
This study evaluated the impact of social support programs on improving cancer related disability, neuro-cognitive dysfunction and enhancing participation (quality of life (QoL), social reintegration) in brain tumour (BT...